Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Strong sell , booom in your dreams . Too late to buy , lol
Thx for cheap share, all weak hands are out
Thx for the 2 you will never see it again, mostly buyer today
That’s right
nnovus Pharmaceuticals Reports Nine Month Net Revenue of $6.4 million and Net Loss Decrease of 51.6% Compared to the Same Period in 2016
$ONOV BioNovelus agrees to Co-Directorship and advisory with Meroe Capital Group Ltd.
November 14, 2017 06:00 ET | Source: BioNovelus Inc.
FOR IMMEDIATE RELEASE — Phoenix, Nov. 14, 2017 (GLOBE NEWSWIRE) -- — BioNovelus (ONOV) has today announced the retention of New York-based Meroe Capital Group Ltd.
In the structure of the deal, BioNovelus will become a client of Meroe Capital’s prestigious “H2O Program II.” the Meroe Capital accelerated business incubator. This setting will provide BioNovelus the required operational and financial initiatives as well as allocations that are custom tailored and necessary to BioNovelus, and such additional resources and talent to further refine, meet and exceed the young company’s current objectives.
The deal, which includes BioNovelus issuing 10 million shares of restricted common stock of ONOV, and (through a Meroe investor) capital to Meroe Group interest that will provide and direct new infrastructure, ancillary firms, and thus, a refined direction to the methodology, technocratic, structural, and strategic direction of BioNovelus for the future.
Mr. Robert Brown, Meroe Capital’s V.P. of Logistics, will direct strategy, logistics coordination, and resources in the repositioning of BioNovelus, its expansion in the capital markets, as well as directing and advising on structural and operational requirements necessary for the company to achieve and exceed its current objectives.
Mr. Jean Ekobo, BioNovelus CEO and founder is pleased with the new relationship. “This is a very natural coming together,” Ekobo said with enthusiasm. “Management believes Meroe’s resources, experience in agri-business and access to capital will provide BioNovelus the reach it requires to effect its objectives quickly. We believe that the “H2O Program II” is right for the Company. We have the same aspirations: a healthier planet and success for our respective companies.”
http://globenewswire.com/news-release/2017/11/14/1185672/0/en/BioNovelus-agrees-to-Co-Directorship-and-advisory-with-Meroe-Capital-Group-Ltd.html
BioNovelus agrees to Co-Directorship and advisory with Meroe Capital Group Ltd.
November 14, 2017 06:00 ET | Source: BioNovelus Inc.
FOR IMMEDIATE RELEASE — Phoenix, Nov. 14, 2017 (GLOBE NEWSWIRE) -- — BioNovelus (ONOV) has today announced the retention of New York-based Meroe Capital Group Ltd.
In the structure of the deal, BioNovelus will become a client of Meroe Capital’s prestigious “H2O Program II.” the Meroe Capital accelerated business incubator. This setting will provide BioNovelus the required operational and financial initiatives as well as allocations that are custom tailored and necessary to BioNovelus, and such additional resources and talent to further refine, meet and exceed the young company’s current objectives.
The deal, which includes BioNovelus issuing 10 million shares of restricted common stock of ONOV, and (through a Meroe investor) capital to Meroe Group interest that will provide and direct new infrastructure, ancillary firms, and thus, a refined direction to the methodology, technocratic, structural, and strategic direction of BioNovelus for the future.
Mr. Robert Brown, Meroe Capital’s V.P. of Logistics, will direct strategy, logistics coordination, and resources in the repositioning of BioNovelus, its expansion in the capital markets, as well as directing and advising on structural and operational requirements necessary for the company to achieve and exceed its current objectives.
Mr. Jean Ekobo, BioNovelus CEO and founder is pleased with the new relationship. “This is a very natural coming together,” Ekobo said with enthusiasm. “Management believes Meroe’s resources, experience in agri-business and access to capital will provide BioNovelus the reach it requires to effect its objectives quickly. We believe that the “H2O Program II” is right for the Company. We have the same aspirations: a healthier planet and success for our respective companies.”
http://globenewswire.com/news-release/2017/11/14/1185672/0/en/BioNovelus-agrees-to-Co-Directorship-and-advisory-with-Meroe-Capital-Group-Ltd.html
Agree , sometimes we need patience
This stock is garbage , my opinion
Right , Sedor is shareholder friendly
That’s the reason that the clowntrader only fool other ... but the gap will still be open. ...
Gap close to 2.50 $ then next price target minimum 3$ , my opinion
ISIG BULLISH , be careful Clay
Thx for information
Today was a 225k buy. I think it is suspended?
No RS, Tenbagger up to now , my opinion
Easily tenbagger up to now
Patience in NOUV will be the winner
easily tenbagger up to now....
That’s sounds good , back to ... we will see
Hola chicko , some big here
Fluffy PR for dillution?
Big buying here , some big is brewing , lol
Thx for information
Someone is still loading ....
Christmas time will come also for $$$$TONR$$$
LOL, you will regret ....
or maybe suspension? Lol
I think it will renewed
I will grab some if you sell .... $$$ONOV$$$
Looking forward to a great week ahead! $$$ONOV$$$
My opinion
I will miss you , lol
„We are on a mission „
https://mobile.twitter.com/BioNovelus/status/913044235590410240
Today business license expired , what happens next?
I believe on the end of october we are back on 5$ , just my opinion
I will look on Monday !
One good news and we are back in the double zero ..... do your DD and all just my opinion
Congratulations L2 , really nice pick , Thx
Nice pick L2
Is this alive?